FDA NDC Directory · JSON-LD · Markdown

RYSTIGGO

NDC 50474-982 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameROZANOLIXIZUMAB
Labeler / ManufacturerUCB, Inc.
Marketing categoryBiologic License Application · App BLA761286
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsROZANOLIXIZUMAB (140 mg/mL)
Marketing started20240614
Package count1

External sources

Source: openFDA. Public-domain (CC0).